Long-term effects of COVID-19 in diabetic and non-diabetic patients
Copyright © 2022 Alberca, Ramos, Pereira, Beserra, Branco, Leão Orfali, Aoki, Duarte and Sato..
The literature presents several reports of the impact of glycemic control and diabetes in the inflammatory and coagulatory response during coronavirus disease 2019 (COVID-19). Nevertheless, the long-term impact of the COVID-19 in diabetic patients is still to be explored. Therefore, we recruited 128 patients and performed a longitudinal analysis on COVID-19-associated biomarkers of patients with COVID-19, tree and 6 months after COVID-19 recovery and put into perspective the possible long-term complication generated after COVID-19. In our investigation, we failed to verify any long-term modification on inflammatory biomarkers, but detected an increase in the glycemia and glycated hemoglobin in patients without any pre-existing history or diagnosis of diabetes (non-diabetic patients). Although diabetic and non-diabetic patients presented elevated levels of glycated hemoglobin, the c-peptide test indicated a normal beta cell function in all patients.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
Frontiers in public health - 10(2022) vom: 01., Seite 963834 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Alberca, Ricardo Wesley [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Biomarkers |
|---|
| Anmerkungen: |
Date Completed 08.09.2022 Date Revised 23.01.2023 published: Electronic-eCollection Citation Status MEDLINE |
|---|
| doi: |
10.3389/fpubh.2022.963834 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM345630637 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM345630637 | ||
| 003 | DE-627 | ||
| 005 | 20231226025518.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fpubh.2022.963834 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1152.xml |
| 035 | |a (DE-627)NLM345630637 | ||
| 035 | |a (NLM)36045733 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Alberca, Ricardo Wesley |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Long-term effects of COVID-19 in diabetic and non-diabetic patients |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.09.2022 | ||
| 500 | |a Date Revised 23.01.2023 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022 Alberca, Ramos, Pereira, Beserra, Branco, Leão Orfali, Aoki, Duarte and Sato. | ||
| 520 | |a The literature presents several reports of the impact of glycemic control and diabetes in the inflammatory and coagulatory response during coronavirus disease 2019 (COVID-19). Nevertheless, the long-term impact of the COVID-19 in diabetic patients is still to be explored. Therefore, we recruited 128 patients and performed a longitudinal analysis on COVID-19-associated biomarkers of patients with COVID-19, tree and 6 months after COVID-19 recovery and put into perspective the possible long-term complication generated after COVID-19. In our investigation, we failed to verify any long-term modification on inflammatory biomarkers, but detected an increase in the glycemia and glycated hemoglobin in patients without any pre-existing history or diagnosis of diabetes (non-diabetic patients). Although diabetic and non-diabetic patients presented elevated levels of glycated hemoglobin, the c-peptide test indicated a normal beta cell function in all patients | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a complications | |
| 650 | 4 | |a glycemic control | |
| 650 | 4 | |a infection | |
| 650 | 7 | |a Biomarkers |2 NLM | |
| 650 | 7 | |a Blood Glucose |2 NLM | |
| 650 | 7 | |a Glycated Hemoglobin A |2 NLM | |
| 700 | 1 | |a Ramos, Yasmim Álefe Leuzzi |e verfasserin |4 aut | |
| 700 | 1 | |a Pereira, Nátalli Zanete |e verfasserin |4 aut | |
| 700 | 1 | |a Beserra, Danielle Rosa |e verfasserin |4 aut | |
| 700 | 1 | |a Branco, Anna Cláudia Calvielli Castelo |e verfasserin |4 aut | |
| 700 | 1 | |a Leão Orfali, Raquel |e verfasserin |4 aut | |
| 700 | 1 | |a Aoki, Valeria |e verfasserin |4 aut | |
| 700 | 1 | |a Duarte, Alberto Jose da Silva |e verfasserin |4 aut | |
| 700 | 1 | |a Sato, Maria Notomi |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Frontiers in public health |d 2013 |g 10(2022) vom: 01., Seite 963834 |w (DE-627)NLM23377548X |x 2296-2565 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2022 |g day:01 |g pages:963834 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3389/fpubh.2022.963834 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2022 |b 01 |h 963834 | ||